Article Details

Dimerix (ASX:DXB) eyes $20m for phase three trials

Retrieved on: 2021-08-16 01:18:23

Tags for this article:

Click the tags to see associated articles and topics

Dimerix (ASX:DXB) eyes $20m for phase three trials. View article details on hiswai:

Excerpt

Dimerix (DXB) receives firm commitments to undertake a two-phase placement to raise $20 million; Roughly 100 million new fully paid ordinary shares ...

Article found on: themarketherald.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up